Melanoma Cancer Diagnostics Market

The Melanoma Cancer Diagnostics Market is segmented by Diagnostic Modality (Dermoscopy & Digital Imaging, Histopathology/Biopsy, Molecular/Genetic Testing, AI-Assisted Skin Analysis, Reflectance Confocal Microscopy), Biomarker Test Type (BRAF Mutation Testing, PD-L1 Expression Testing, NRAS Mutation Testing, LDH Serum Marker Testing, ctDNA/Liquid Biopsy), and Region. Forecast for 2026 to 2036.